In contrast, CRP and PCT are more suited for monitoring disease progression, underscoring the importance of a multifaceted approach to sepsis management that incorporates both early prognostic markers and ongoing monitoring of clinical dynamics. This evidence concerns the gene CRP and Sepsis.